Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2021-12-16 to 2022-01-10
Current total value of award: $16218.32
Description: 4555795240!TYSABRI 300 MG/15 ML VIAL 15ML